2021
DOI: 10.2147/sccaa.s300939
|View full text |Cite
|
Sign up to set email alerts
|

The Potentiality of Human Umbilical Cord Isolated Mesenchymal Stem/Stromal Cells for Cardiomyocyte Generation [Corrigendum]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…To obtain good outcomes in stem cell therapy, it is critical to prepare stem cells with a high therapeutic potential for transplantation. The synergic effect of 5-Aza and bFGF in MSCs confirmed through a high expression of TNNT1, Desmin, and NKX2.5 as the cardiac-specific biomarkers [ 32 ].…”
Section: Discussionmentioning
confidence: 99%
“…To obtain good outcomes in stem cell therapy, it is critical to prepare stem cells with a high therapeutic potential for transplantation. The synergic effect of 5-Aza and bFGF in MSCs confirmed through a high expression of TNNT1, Desmin, and NKX2.5 as the cardiac-specific biomarkers [ 32 ].…”
Section: Discussionmentioning
confidence: 99%
“…5-AZA, widely used in the cardiac differentiation of stem cells, can regulate the histone demethylation and DNA methylation (20). A number of stem cells have been used to differentiate into cardiomyocytes by 5-AZA (19)(20)(21)(22)(23). The mechanism of 5-AZA may be related to CpG base-pair demethylation and regulation of early myocardial transcription factors (24)(25)(26)(27).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, umbilical cord HSCs have a competitive advantage over bone marrow hematopoietic stem cells because they graft 10-50 times better on host xenogenic. Still, their percentage among mononuclear cells decreases with gestational age, from 11% at 17 weeks to 1% at 38 weeks (16).…”
Section: Introductionmentioning
confidence: 92%